Sharekhan

Epigral Ltd

Fri 20/02/2026,15:45:46 | NSE : EPIGRAL

₹ 940.40-39.20 (-4.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 982.00

Previous Close

₹ 979.60

Volume

76150

Mkt Cap ( Rs. Cr)

₹4057.01

High

₹ 982.00

Low

₹ 937.30

52 Week High

₹ 2114.00

52 Week Low

₹ 904.60

Book Value Per Share

₹ 487.03

Dividend Yield

0.61

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Epigral Ltd

Your Vote -

Buy

54.08%

Hold

41.84%

Sell

4.08%

54.08%

98 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

940.40

220

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

220

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Epigral Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Feb 2026, 3:38PM Epigral Limited has informed the Exchange about Participation in Conference and One-on-One Meeting with Analyst / Investor on 10.02.2026.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Feb 2026, 3:35PM Epigral Limited has informed the Exchange about Participation in Conference and One-on-One Meeting with Analyst / Investor on 10.02.2026
  • Epigral Limited Earns Silver Medal from EcoVadis

    3 Feb 2026, 5:22PM Epigral Limited, one of India’s leading integrated chemical manufacturers, has been awarded the EcoVadis Silver Medal in recognition of its sust
  • Epigral - Press Release

    3 Feb 2026, 4:53PM Epigral Limited has informed the Exchange regarding a press release dated February 03, 2026, titled ""Press Release titled Epigral Limited awarded Ec
  • Epigral - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    3 Feb 2026, 4:51PM Epigral Limited submits Press release titled \Epigral Limited awarded EcoVadis Silver Medal\.
  • Epigral - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    3 Feb 2026, 4:43PM Epigral Limited submits Transcript of Conference Call held on Friday, 30th January, 2026 for Q3 FY26 - Results.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Feb 2026, 4:38PM Epigral Limited submits Transcript of Conference Call held on Friday, 30th January, 2026 for Q3 FY26 Results.
  • Epigral - Copy of Newspaper Publication

    31 Jan 2026, 12:12PM Epigral Limited submits copy of Newspaper Publication pertaining to Un-Audited Financial Results - 31.12.2025
  • Epigral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    31 Jan 2026, 10:37AM Epigral Limited submits Audio recording of Conference Call discussing Q3 FY26 Results.
  • Epigral - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Jan 2026, 10:32AM Epigral Limited has informed the Exchange about Link of Recording
  • Epigral - Investor Presentation

    30 Jan 2026, 2:37PM Epigral Limited has informed the Exchange about Investor Presentation
  • Epigral - Press Release

    30 Jan 2026, 2:35PM Epigral Limited has informed the Exchange regarding a press release dated January 30, 2026, titled ""Press Release on Un-Audited Financial Results Q
  • Epigral - Outcome of Board Meeting

    30 Jan 2026, 2:34PM Epigral Limited has informed the Exchange regarding Board meeting held on January 30, 2026.
  • Epigral - Outcome of Board Meeting

    30 Jan 2026, 2:28PM Epigral Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
  • Epigral - Announcement under Regulation 30 (LODR)-Investor Presentation

    30 Jan 2026, 2:43PM Investor Presentation on Un-Audited Financial Results -Q3 FY26.
  • Epigral - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 Jan 2026, 2:41PM Press Release on Un-Audited Financial Results - Q3 FY26.
  • Epigral Q3 net profit down 62.19% at Rs 39.15 cr

    30 Jan 2026, 2:40PM The company reported standalone net profit of Rs 39.15 crore for the quarter ended December 31, 2025 as compared to Rs 103.54 crore in the same period
  • Epigral - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 30Th January, 2026 And Submission Of Un-Audited

    30 Jan 2026, 2:33PM Outcome of Board Meeting held on Friday, 30th January, 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the Third Q
  • Epigral - UNAUDITED FINANCIAL RESULTS AS ON 31.12.2025.

    30 Jan 2026, 2:31PM UNAUDITED FINANCIAL RESULTS AS ON 31.12.2025.
  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    23 Jan 2026, 1:07PM The Company is having Conference call to discuss the Q3FY26 results on Friday, 30th January, 2026 at 05:00 p.m. (IST).
  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 Jan 2026, 1:06PM The Company is having Conference call to discuss the Q3FY26 results on Friday, 30th January, 2026 at 05:00 p.m. (IST).
  • Epigral Ltd - Board Meeting Intimation for Consider And Approval Of Un-Audited Financial Results (Standalone & Consolidated)

    20 Jan 2026, 12:51PM Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve
  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    15 Jan 2026, 9:17AM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 16th January, 2026.
  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    15 Jan 2026, 9:23AM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 16th January, 2026.
  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Jan 2026, 3:09PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 13th January, 2026.
  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Jan 2026, 3:11PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 13th January, 2026.
  • Epigral Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    10 Jan 2026, 2:42PM As of December 2025, 68.83% is owned by Indian Promoters and 31.17% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Epigral Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 6:20PM Epigral Limited submits Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 31.12.2025.
  • Epigral Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jan 2026, 6:17PM Epigral Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Epigral Ltd - Action(s) initiated or orders passed

    1 Jan 2026, 4:32PM Epigral Limited has informed the Exchange about Intimation for receipt of Order from Income Tax Department.
  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    1 Jan 2026, 4:24PM Intimation for receipt of Order from Income Tax Department.
  • Epigral Ltd - Trading Window

    26 Dec 2025, 3:33PM Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Dec 2025, 5:55PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 23rd December, 2025
  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 Dec 2025, 5:57PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 23rd December, 2025
  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Nov 2025, 2:37PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 1st December, 2025
  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Nov 2025, 2:35PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 1st December, 2025
  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 Nov 2025, 6:07PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 1st December, 2025.
  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    26 Nov 2025, 6:05PM Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 1st December, 2025
  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    21 Nov 2025, 11:12AM Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on 25.11.2025.
  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    21 Nov 2025, 11:11AM Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on 25.11.2025.
  • Meghmani Finechem commissions captive PowerPlant of 36 MW at Dahej

    30 Sep 2022 , 10:50AM Meghmani Finechem commissions additional 1.06 lakh TPA capacity of caustic soda at Dahej
  • Meghmani Finechem commissions CPVC resin plant in Gujarat

    18 Jul 2022 , 12:12PM Meghmani Finechem commissions India’s largest Chlorinated Polyvinyl Chloride Resin (CPVC Resin) plant

Key fundamentals

Evaluate the intrinsic value of Epigral Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 2488.11 2216.7777 1945.3109 1715.3315 1099.6362
Liabilities 2488.11 2216.7777 1945.3109 1715.3315 1099.6362
Equity 43.14 41.5502 41.5502 41.5502 41.5527
Gross Profit 710.72 481.2096 688.9974 509.4874 261.3271
Net Profit 356.7 195.7877 353.3575 252.7868 100.839
Cash From Operating Activities 440.56 397.6901 626.1617 283.8167 229.2156
NPM(%) 13.98 10.14 16.14 16.29 12.16
Revenue 2550.13 1929.1916 2188.3997 1550.9414 828.6003
Expenses 1839.41 1447.982 1499.4023 1041.454 567.2732
ROE(%) 16.97 9.31 16.81 12.03 4.79

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
20 Jun 2025 3.5 35 0.64 1779.6
07 Feb 2025 2.5 25 0.64 1788.2
02 Jul 2024 5 50 0.64 1398.9
20 Jun 2023 2.5 25 0.64 990.65
01 Feb 2023 2.5 25 0.64 1143.4

Peers

Other companies within the same industry or sector that are comparable to Epigral Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 1202.90 2.52 19.18 8856.95 337.37 0.75
Amines and Plasticizers Ltd 164.26 0.33 26.58 5401.31 372.61 0.30
Indogulf Cropsciences Ltd 65.27 -0.35 10.81 4789.42 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 37.41 44511.46 346.70 0.43

Company Info

Our Company was incorporated as "Meghmani Finechem Limited" on September 11, 2007 under the Companies Act, 1956 in the state of Gujarat vide Certificate of Incorporation issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli ("RoC"). Our Company obtained Certificate of Commencement of Business on September 17, 2007 issued by RoC.Key Events and Milestones:2007 -Received Certificate of Commencement of Business2008 -International Finance Corporation (World Bank) joined as a partner with 24.97% stake2010 -Started Operation from July 2009 as Greenfield Project of 1,19,000-FY 2010 TPA of Caustic Chlorine and Captive Power Plant of 40MW2015 -Expanded Caustic Chlorine to 1,67,000 TPA with 60MW Captive Power Plant2017 -Commissioned KOH Plant of 21,000 TPA and Convert all Membrane to FY 2017 ZERO Gap2018-Planned for New Caustic Expansion and Chlor-Alkali Derivatives (Chloromethane and Hydrogen Peroxide)-Achieved Turnover of USD 95 Million (? 609 Cr.)2019-Commissioned Chloromethane Plant2020-Commenced the Commercial Operations of Caustic Soda Lye Expansion of 140000 TPA with Captive Power Plant of 36 MW-Announcement for setting up new Epichlorohydrin Plant with 50,000 TPA capacity-Expanded Caustic Chlorine Capacity to 294,000TPA-Expanded capacity of Captive Power Plant to 96MW-Commissioned 60,000 TPA Hydrogen Peroxide Plant 2022 - The Company announced the successful commissioning of chlorinated polyvinyl chloride resin (CPVC resin) plant at Dahej in Gujarat. The newly-commissioned facility with a production capacity of 30,000 tonnes per annum (TPA) is the largest of its kind in India.  2023  -Company name has changed to Epigral Ltd. from Meghmani Finechem Ltd.. - 'Commissioning of Wind Solar Hybrid Power Plant'.  2024 -The Company Informed Commissioning of CPVC Compound Plant at its Dahej Facility at Gujarat.

Our Company was incorporated as "Meghmani Finechem Limited" on September 11, 2007 under the Companies Act, 1956 in the state of Gujarat vide Certificate of Incorporation issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli ("RoC"). Our Company obtained Certificate of Commencement of Business on September 17, 2007 issued by RoC.Key Events and Milestones:2007 -Received Certificate of Commencement of Business2008 -International Finance Corporation (World Bank) joined as a partner with 24.97% stake2010 -Started Operation from July 2009 as Greenfield Project of 1,19,000-FY 2010 TPA of Caustic Chlorine and Captive Power Plant of 40MW2015 -Expanded Caustic Chlorine to 1,67,000 TPA with 60MW Captive Power Plant2017 -Commissioned KOH Plant of 21,000 TPA and Convert all Membrane to FY 2017 ZERO Gap2018-Planned for New Caustic Expansion and Chlor-Alkali Derivatives (Chloromethane and Hydrogen Peroxide)-Achieved Turnover of USD 95 Million (? 609 Cr.)2019-Commissioned Chloromethane Plant2020-Commenced the Commercial Operations of Caustic Soda Lye Expansion of 140000 TPA with Captive Power Plant of 36 MW-Announcement for setting up new Epichlorohydrin Plant with 50,000 TPA capacity-Expanded Caustic Chlorine Capacity to 294,000TPA-Expanded capacity of Captive Power Plant to 96MW-Commissioned 60,000 TPA Hydrogen Peroxide Plant 2022 - The Company announced the successful commissioning of chlorinated polyvinyl chloride resin (CPVC resin) plant at Dahej in Gujarat. The newly-commissioned facility with a production capacity of 30,000 tonnes per annum (TPA) is the largest of its kind in India.  2023  -Company name has changed to Epigral Ltd. from Meghmani Finechem Ltd.. - 'Commissioning of Wind Solar Hybrid Power Plant'.  2024 -The Company Informed Commissioning of CPVC Compound Plant at its Dahej Facility at Gujarat.

Read More

Parent Organisation

Epigral Ltd.

Founded

11/09/2007

Managing Director

Mr.Maulik Patel

NSE Symbol

EPIGRALEQ

FAQ

The current price of Epigral Ltd is ₹ 940.40.

The 52-week high for Epigral Ltd is ₹ 982.00 and the 52-week low is ₹ 937.30.

The market capitalization of Epigral Ltd is currently ₹ 4057.01. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Epigral Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Epigral Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Epigral Ltd shares.

The CEO of Epigral Ltd is Mr.Maulik Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT